TP53 and neoplasm: From a molecular point of view, F10503LO1 decreased the content of phospho-AKT, and phospho-AMPK, impaired angiogenesis through a decrease in the intratumor content of VEGF and decreased p53 levels suggesting a specific mechanism leading to a reduced in vivo viability of B16F10 cells and tumor dissemination.